- Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
- Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
- Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
- Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study
- Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
- Structure Therapeutics Announces $300 Million Private Placement Equity Financing
- Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
- Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
- Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
More ▼
Key statistics
On Tuesday, Structure Therapeutics Inc (GPCR:NMQ) closed at 37.08, 45.01% above the 52 week low of 25.57 set on Aug 17, 2023.
52-week range
Open | 37.32 |
---|---|
High | 38.30 |
Low | 35.42 |
Bid | 35.65 |
Offer | 38.50 |
Previous close | 37.08 |
Average volume | 539.93k |
---|---|
Shares outstanding | 46.62m |
Free float | 35.44m |
P/E (TTM) | -- |
Market cap | 1.73bn USD |
EPS (TTM) | -2.32 USD |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
More ▼